{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:29:52Z","timestamp":1773052192509,"version":"3.50.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:00:00Z","timestamp":1550620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0211404","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T14:51:20Z","timestamp":1550674280000},"page":"e0211404","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barr\u00e9 syndrome"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3482-7335","authenticated-orcid":true,"given":"Nikki","family":"van Leeuwen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Walgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter A.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart C.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewout W.","family":"Steyerberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hester F.","family":"Lingsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,2,20]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jclinepi.2014.11.001","article-title":"Covariate adjustment had similar benefits in small and large randomized controlled trials","volume":"68","author":"DD Thompson","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nurt.2009.10.020","article-title":"IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury","volume":"7","author":"AI Maas","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1161\/STROKEAHA.106.474080","article-title":"Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials","volume":"38","author":"PM Bath","year":"2007","journal-title":"Stroke"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/STROKEAHA.108.519207","article-title":"Should stroke trials adjust functional outcome for baseline prognostic factors?","volume":"40","author":"LJ Gray","year":"2009","journal-title":"Stroke"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/neu.2006.23.1295","article-title":"Adjustment for strong predictors of outcome in traumatic brain injury trials: 25% reduction in sample size requirements in the IMPACT study","volume":"23","author":"AV Hernandez","year":"2006","journal-title":"J Neurotrauma"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jclinepi.2003.09.014","article-title":"Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements","volume":"57","author":"AV Hernandez","year":"2004","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1097\/CCM.0b013e3181ab85ec","article-title":"Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?","volume":"37","author":"B Roozenbeek","year":"2009","journal-title":"Crit Care Med"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0002-8703(00)90001-2","article-title":"Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics?","volume":"139","author":"EW Steyerberg","year":"2000","journal-title":"Am Heart J"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jclinepi.2011.08.012","article-title":"Covariate adjustment increased power in randomized controlled trials: an example in traumatic brain injury","volume":"65","author":"EL Turner","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"24","key":"ref10","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1002\/sim.2678","article-title":"Proportional odds logistic regression\u2014effective means of dealing with limited uncertainty in dichotomizing clinical outcomes","volume":"25","author":"Z Valenta","year":"2006","journal-title":"Stat Med"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1740774509356580","article-title":"A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project","volume":"7","author":"GS McHugh","year":"2010","journal-title":"Clin Trials"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/cc10240","article-title":"The added value of ordinal analysis in clinical trials: an example in traumatic brain injury","volume":"15","author":"B Roozenbeek","year":"2011","journal-title":"Crit Care"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1161\/STROKEAHA.107.488536","article-title":"Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials","volume":"38","author":"JL Saver","year":"2007","journal-title":"Stroke"},{"issue":"9497","key":"ref14","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barre syndrome","volume":"366","author":"RA Hughes","year":"2005","journal-title":"Lancet"},{"issue":"Suppl 2","key":"ref15","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain-Barre syndrome","volume":"176","author":"RA Hughes","year":"1997","journal-title":"J Infect Dis"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/jnnp.2006.102731","article-title":"Treatment of Guillain-Barre syndrome with mycophenolate mofetil: a pilot study","volume":"78","author":"MP Garssen","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"17","key":"ref17","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group","volume":"326","author":"FG van der Meche","year":"1992","journal-title":"N Engl J Med"},{"issue":"9404","key":"ref18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","article-title":"Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomised trial","volume":"363","author":"R van Koningsveld","year":"2004","journal-title":"Lancet"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A clinical prognostic scoring system for Guillain-Barre syndrome","volume":"6","author":"R van Koningsveld","year":"2007","journal-title":"Lancet Neurol"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barre syndrome","volume":"76","author":"C Walgaard","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"ref21","first-page":"227","article-title":"Some Surprising Results about Covariate Adjustment in Logistic Regression Models","volume":"59","author":"LD Robinson","year":"1991","journal-title":"International Statistical Review \/ Revue Internationale de Statistique"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0895-4356(91)90203-L","article-title":"A consequence of omitted covariates when estimating odds ratios","volume":"44","author":"WW Hauck","year":"1991","journal-title":"J Clin Epidemiol"},{"issue":"6942","key":"ref23","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1136\/bmj.308.6942.1499","article-title":"Regression towards the mean","volume":"308","author":"JM Bland","year":"1994","journal-title":"BMJ"},{"issue":"6957","key":"ref24","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/bmj.309.6957.780","article-title":"Some examples of regression towards the mean","volume":"309","author":"JM Bland","year":"1994","journal-title":"BMJ"},{"issue":"7321","key":"ref25","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/bmj.323.7321.1123","article-title":"Statistics notes: Analysing controlled trials with baseline and follow up measurements","volume":"323","author":"AJ Vickers","year":"2001","journal-title":"BMJ"},{"issue":"9209","key":"ref26","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0140-6736(00)02039-0","article-title":"Subgroup analysis and other (mis)uses of baseline data in clinical trials","volume":"355","author":"SF Assmann","year":"2000","journal-title":"Lancet"},{"issue":"19","key":"ref27","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/sim.1296","article-title":"Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems","volume":"21","author":"SJ Pocock","year":"2002","journal-title":"Stat Med"},{"issue":"22","key":"ref28","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/sim.4780122208","article-title":"A random effects model for ordinal responses from a crossover trial","volume":"12","author":"S. Senn","year":"1993","journal-title":"Stat Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0211404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:56:40Z","timestamp":1588960600000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0211404"}},"subtitle":[],"editor":[{"given":"Yu Ru","family":"Kou","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,20]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0211404","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,20]]}}}